- Home
- TAC vs ALVO Comparison
TAC vs ALVO Comparison
Compare TAC & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAC
- ALVO
- Stock Information
- Founded
- TAC 1909
- ALVO 2013
- Country
- TAC Canada
- ALVO Luxembourg
- Employees
- TAC N/A
- ALVO N/A
- Industry
- TAC Electric Utilities: Central
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- TAC Utilities
- ALVO Health Care
- Exchange
- TAC Nasdaq
- ALVO Nasdaq
- Market Cap
- TAC 4.0B
- ALVO 3.4B
- IPO Year
- TAC N/A
- ALVO N/A
- Fundamental
- Price
- TAC $9.58
- ALVO $9.19
- Analyst Decision
- TAC Buy
- ALVO Buy
- Analyst Count
- TAC 1
- ALVO 1
- Target Price
- TAC $19.50
- ALVO $18.00
- AVG Volume (30 Days)
- TAC 1.4M
- ALVO 126.8K
- Earning Date
- TAC 05-02-2025
- ALVO 05-20-2025
- Dividend Yield
- TAC 1.82%
- ALVO N/A
- EPS Growth
- TAC N/A
- ALVO N/A
- EPS
- TAC 0.41
- ALVO N/A
- Revenue
- TAC $1,977,287,259.00
- ALVO $491,978,000.00
- Revenue This Year
- TAC N/A
- ALVO $17.94
- Revenue Next Year
- TAC N/A
- ALVO $53.52
- P/E Ratio
- TAC $23.52
- ALVO N/A
- Revenue Growth
- TAC N/A
- ALVO 426.85
- 52 Week Low
- TAC $5.94
- ALVO $9.15
- 52 Week High
- TAC $14.64
- ALVO $14.76
- Technical
- Relative Strength Index (RSI)
- TAC 44.04
- ALVO 23.54
- Support Level
- TAC $9.18
- ALVO $9.24
- Resistance Level
- TAC $9.88
- ALVO $9.90
- Average True Range (ATR)
- TAC 0.25
- ALVO 0.39
- MACD
- TAC 0.06
- ALVO -0.19
- Stochastic Oscillator
- TAC 49.38
- ALVO 1.53
About TAC TransAlta Corporation
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse and growing fleet of electrical power generation assets in Canada, the United States, and Australia. The company has six reportable segments namely, hydro, wind & solar, Energy Marketing, gas, energy transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.